Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2026 -1.18K%
June 30, 2026 -1.39K%
March 31, 2026 -1.50K%
December 31, 2025 -666.1%
September 30, 2025 -2.18K%
June 30, 2025 -716.8%
March 31, 2025 -2.78K%
December 31, 2024 -1.40K%
September 30, 2024 -1.94K%
June 30, 2024 -506.0%
March 31, 2024 -773.3%
December 31, 2023 -1.09K%
September 30, 2023 -6.37K%
June 30, 2023 -2.83K%
March 31, 2023 -1.45K%
December 31, 2022 6.63%
September 30, 2022 -3.30K%
June 30, 2022 -7.86K%
March 31, 2022 -2.60K%
December 31, 2021 14.23%
September 30, 2021 -1.84K%
June 30, 2021 86.12%
March 31, 2021 -9.15K%
December 31, 2020 -2.05%
September 30, 2020 -3.01K%
Date Value
June 30, 2020 -2.77K%
March 31, 2020 -26.92K%
December 31, 2019 -1.58K%
September 30, 2019 -2.26K%
June 30, 2019 -1.27K%
March 31, 2019 -2.44K%
December 31, 2018 -1.36K%
September 30, 2018 -700.0%
June 30, 2018 -675.1%
March 31, 2018 -540.2%
December 31, 2017 -1.06K%
September 30, 2017 -453.3%
June 30, 2017 -430.4%
March 31, 2017 -610.4%
December 31, 2016
September 30, 2016 -211.5%
June 30, 2016 -490.5%
March 31, 2016 -519.2%
December 31, 2015 -397.2%
September 30, 2015 -820.5%
June 30, 2015 -1.17K%
March 31, 2015 -1.14K%
December 31, 2014 -758.2%
September 30, 2014 -905.0%
June 30, 2014 -862.8%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Cartesian Therapeutics, Inc. --
Moderna, Inc. 12.34%
GRAIL, Inc. -275.9%
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. -2.15K%